UBS AM’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $922K | Buy |
81,999
+37,735
| +85% | +$425K | ﹤0.01% | 2401 |
|
|
2025
Q1 | $252K | Buy |
44,264
+2,269
| +5% | +$12.9K | ﹤0.01% | 2566 |
|
|
2024
Q4 | $412K | Buy |
41,995
+5,746
| +16% | +$56.4K | ﹤0.01% | 2582 |
|
|
2024
Q3 | $295K | Sell |
36,249
-11,291
| -24% | -$92K | ﹤0.01% | 2731 |
|
|
2024
Q2 | $635K | Buy |
47,540
+11,729
| +33% | +$157K | ﹤0.01% | 2557 |
|
|
2024
Q1 | $1.66M | Hold |
35,811
| – | – | ﹤0.01% | 1771 |
|
|
2023
Q4 | $2.42M | Buy |
35,811
+1,820
| +5% | +$123K | ﹤0.01% | 1591 |
|
|
2023
Q3 | $2.46M | Buy |
33,991
+4,484
| +15% | +$325K | ﹤0.01% | 1520 |
|
|
2023
Q2 | $1.57M | Hold |
29,507
| – | – | ﹤0.01% | 1780 |
|
|
2023
Q1 | $1.57M | Hold |
29,507
| – | – | ﹤0.01% | 1780 |
|
|
2022
Q4 | $1.99M | Buy |
29,507
+6,939
| +31% | +$469K | ﹤0.01% | 1526 |
|
|
2022
Q3 | $2.82M | Sell |
22,568
-4,985
| -18% | -$622K | ﹤0.01% | 1420 |
|
|
2022
Q2 | $2.62M | Buy |
+27,553
| New | +$2.62M | ﹤0.01% | 1504 |
|